Tumor Microenvironment-Responsive Polymeric Nanocarriers for the Treatment of Triple-Negative Breast Cancer
Open Access
- 28 August 2026
- journal article
- review article
- Published by MDPI AG in Pharmaceutics
- Vol. 18 (9) , 1083
Abstract
Triple-negative breast cancer (TNBC) is an aggressive and heterogeneous subtype lacking effective targeted therapies. Its tumor microenvironment (TME) exhibits distinct features, including acidity, redox imbalance, elevated reactive oxygen species (ROS), and hypoxia, which provide exploitable triggers for targeted drug delivery. Stimuli-responsive polymeric nanocarriers have emerged as promising platforms that enable spatiotemporally controlled and site-specific therapeutic release in response to these endogenous cues, as well as exogenous stimuli such as temperature and light. These systems improve drug accumulation, penetration, and therapeutic efficacy while reducing systemic toxicity. Unlike previous reviews that broadly discuss nanocarriers in cancer therapy, this review focuses on the structure–function relationships of TME-responsive polymeric systems in TNBC and their translational limitations. We summarize recent advances in pH-, redox-, ROS-, hypoxia-, photo- and temperature-responsive polymers, highlighting their design strategies and therapeutic applications. Key challenges, including stimulus heterogeneity, limited in vivo validation, and clinical translation barriers, are also discussed. This review provides a concise framework for the rational design of programmable, multi-responsive polymeric nanomedicines for TNBC therapy.Keywords
This publication has 147 references indexed in Scilit:
- A Mechanistic Understanding of Reactive Oxygen Species (ROS)‐Responsive Bio‐Polymeric Nanoparticles: Current State, Challenges and Future Toward Precision TherapeuticsBiopolymers, 2025
- Tumor Microenvironment‐Responsive Polymer Delivery Platforms for Cancer TherapyAngewandte Chemie, 2025
- Thermo‐Responsive Polymer‐Based Nanoparticles: From Chemical Design to Advanced ApplicationsMacromolecular Rapid Communications, 2025
- Advanced Polymeric Nanoparticles for Cancer Immunotherapy: Materials Engineering, Immunotherapeutic Mechanism and Clinical TranslationAdvanced Materials, 2025
- Nanotechnology and Cancer Bioelectricity: Bridging the Gap Between Biology and Translational MedicineAdvanced Science, 2023
- Redox‐Responsive Polymeric Nanoparticle for Nucleic Acid Delivery and Cancer Therapy: Progress, Opportunities, and ChallengesMacromolecular Bioscience, 2023
- Redox‐Responsive Self‐Assembled Nanoparticles for Cancer TherapyAdvanced Healthcare Materials, 2020
- Enhanced therapeutic efficacy of clotrimazole by delivery through poly(ethylene oxide)‐block‐poly(ε‐caprolactone) copolymer‐based micellesJournal of Applied Polymer Science, 2019
- Chromatographic characterization of amphiphilic di‐ and tri‐block copolymers of poly(ethylene oxide) and poly(ε‐caprolactone)Journal of Separation Science, 2018
- Reactive Oxygen Species (ROS) Responsive Polymers for Biomedical ApplicationsMacromolecular Bioscience, 2016